Insurance
Marketing
Pharmaceuticals
Technology/Innovation
Regulatory
Community
Abbvie
Press release submission
| Jul 24, 2021
DALVANCE® (dalbavancin) Receives FDA Approval to Treat Acute Bacterial Skin and Skin Structure Infections in Pediatric Patients
Press release submission
| Aug 15, 2020
ABBVIE: New England Journal of Medicine Publishes Positive Phase 3 Data of Venetoclax Combination in Acute Myeloid Leukemia (AML) Patients
Press release submission
| Nov 26, 2018
ABBVIE: Receives US FDA Accelerated Approval for VENCLEXTA® (venetoclax) for Treatment of Newly-Diagnosed Acute Myeloid Leukemia Patients Ineligible for Intensive Chemotherapy
Press release submission
| Sep 23, 2018
ABBVIE: Announces $5 Million Donation to Family Reach to Support Children Battling Cancer and Their Families
Carrie Bradon
| Nov 28, 2017
AbbVie to take part in Evercore ISI Biopharma Catalyst conference
Kathy Adams
| Nov 15, 2017
AbbVie executive to present at Jefferies London Healthcare Conference
Robert Hadley
| Nov 7, 2017
FDA fast-tracking review for AbbVie’s endometriosis drug
Mark Iandolo
| Nov 1, 2017
AbbVie to present abstracts on its investigational immunology medicine portfolio
Trending
+
Marketing
Patient Daily
| Apr 22, 2024
Medfluence Senior Director of Business Development on healthcare marketing: 'Patient experience matters more than ever in patient acquisition'
+
Pharmaceuticals
Patient Daily
| Apr 24, 2024
Researchers Look for Long-Term Hearing Loss Treatments
+
Pharmaceuticals
Patient Daily
| Apr 24, 2024
American Lung Association Report: Utah Receives Poor Grades for Ozone and Particle Pollution
+
Pharmaceuticals
Patient Daily
| Apr 23, 2024
Kentucky Father with Terminal Lung Cancer Now Cancer-Free After Innovative Double-Lung Transplant at Northwestern Medicine
1
2
3
4
»
Last »